BSE Live
Oct 31, 16:01Prev. Close
381.75
Open Price
388.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:40Prev. Close
384.30
Open Price
387.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
388.35 (30)
| Profit & Loss account of Kilitch Drugs (India) (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 180.51 | 130.83 | 117.04 | 103.88 | 69.62 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 180.51 | 130.83 | 117.04 | 103.88 | 69.62 | |
| Total Operating Revenues | 181.59 | 131.60 | 117.78 | 105.16 | 70.02 | |
| Other Income | 13.72 | 6.19 | 4.60 | 4.56 | 4.19 | |
| Total Revenue | 195.30 | 137.79 | 122.38 | 109.72 | 74.21 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 93.19 | 66.33 | 58.27 | 60.29 | 37.97 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -1.17 | -0.12 | 0.23 | -0.05 | 1.09 | |
| Employee Benefit Expenses | 10.03 | 7.91 | 7.47 | 6.15 | 5.22 | |
| Finance Costs | 2.13 | 1.91 | 0.99 | 0.66 | 0.75 | |
| Depreciation And Amortisation Expenses | 1.74 | 1.24 | 1.34 | 0.96 | 1.14 | |
| Other Expenses | 48.70 | 37.15 | 34.65 | 27.77 | 20.53 | |
| Total Expenses | 154.61 | 114.43 | 102.93 | 95.79 | 66.70 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 40.69 | 23.35 | 19.45 | 13.93 | 7.51 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 40.69 | 23.35 | 19.45 | 13.93 | 7.51 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 9.85 | 6.37 | 4.20 | 3.63 | 1.67 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.32 | -0.59 | -0.47 | -0.23 | -0.31 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 9.53 | 5.78 | 3.73 | 3.40 | 1.35 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 31.16 | 17.57 | 15.72 | 10.53 | 6.16 | |
| Profit/Loss From Continuing Operations | 31.16 | 17.57 | 15.72 | 10.53 | 6.16 | |
| Profit/Loss For The Period | 31.16 | 17.57 | 15.72 | 10.53 | 6.16 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 19.37 | 11.03 | 10.09 | 6.76 | 3.98 | |
| Diluted EPS (Rs.) | 19.37 | 11.03 | 10.09 | 6.76 | 3.98 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
20.05.2025
Kilitch Drugs Consolidated March 2025 Net Sales at Rs 61.23 crore, up 36.61% Y-o-Y
20.05.2025
Kilitch Drugs Standalone March 2025 Net Sales at Rs 56.30 crore, up 43.87% Y-o-Y
28.02.2025
Kilitch Drugs Consolidated December 2024 Net Sales at Rs 56.17 crore, up 76.65% Y-o-Y
17.02.2025
Kilitch Drugs Standalone December 2024 Net Sales at Rs 46.51 crore, up 56.27% Y-o-Y